High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. - Schellong,G.; Potter,R.; Brämswig,J.; Wagner,W.; Prott,F.J.; Dorffel,W.; Körholz,D.; Mann,G.; Rath,B.; Reiter,A.; Weissbach,G.; Riepenhausen,M.; et al. (J Clin Oncol, 1999)